Literature DB >> 22390807

HDL dysfunction in diabetes: causes and possible treatments.

Dan Farbstein1, Andrew P Levy.   

Abstract

HDL is known to be inversely correlated with cardiovascular disease due to its diverse antiatherogenic functions. These functions include cholesterol efflux and reverse cholesterol transport, antioxidative and anti-inflammatory activities. However, HDL has been shown to undergo a loss of function in several pathophysiological states, as in the acute phase response, obesity and chronic inflammatory diseases. Some of these diseases were also shown to be associated with increased risk for cardiovascular disease. One such disease that is associated with HDL dysfunction and accelerated atherosclerosis is diabetes mellitus, a disease in which the HDL particle undergoes diverse structural modifications that result in significant changes in its function. This review will summarize the changes that occur in HDL in diabetes mellitus and how these changes lead to HDL dysfunction. Possible treatments for HDL dysfunction are also briefly described.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22390807      PMCID: PMC3332215          DOI: 10.1586/erc.11.182

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  102 in total

Review 1.  The role of dysfunctional HDL in atherosclerosis.

Authors:  Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; G M Anantharamaiah; Alan M Fogelman
Journal:  J Lipid Res       Date:  2008-10-27       Impact factor: 5.922

2.  A pivotal role of the human kidney in catabolism of HDL protein components apolipoprotein A-I and A-IV but not of A-II.

Authors:  Jonas Heilskov Graversen; Graciela Castro; Abdelmejid Kandoussi; Henning Nielsen; Erik Ilsø Christensen; Anthony Norden; Søren Kragh Moestrup
Journal:  Lipids       Date:  2008-03-19       Impact factor: 1.880

3.  Haptoglobin binds apolipoprotein E and influences cholesterol esterification in the cerebrospinal fluid.

Authors:  Alfonso Salvatore; Luisa Cigliano; Alessandro Carlucci; Enrico M Bucci; Paolo Abrescia
Journal:  J Neurochem       Date:  2009-04-27       Impact factor: 5.372

4.  Inflammation impairs reverse cholesterol transport in vivo.

Authors:  Fiona C McGillicuddy; Margarita de la Llera Moya; Christine C Hinkle; Michelle R Joshi; Elise H Chiquoine; Jeffrey T Billheimer; George H Rothblat; Muredach P Reilly
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

5.  HbA1c negatively correlates with LCAT activity in type 2 diabetes.

Authors:  Manouchehr Nakhjavani; Alireza Esteghamati; Fatemeh Esfahanian; Azam Ghanei; Armin Rashidi; Saeideh Hashemi
Journal:  Diabetes Res Clin Pract       Date:  2008-05-15       Impact factor: 5.602

6.  Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein.

Authors:  Junji Watanabe; Victor Grijalva; Susan Hama; Karen Barbour; Franklin G Berger; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Journal:  J Biol Chem       Date:  2009-05-11       Impact factor: 5.157

7.  Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I.

Authors:  Baohai Shao; Giorgio Cavigiolio; Nathan Brot; Michael N Oda; Jay W Heinecke
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

8.  Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2.

Authors:  D van Deursen; H Jansen; A J M Verhoeven
Journal:  Diabetologia       Date:  2008-08-30       Impact factor: 10.122

9.  Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes.

Authors:  Bruno Vergès; Emmanuel Florentin; Sabine Baillot-Rudoni; Jean-Michel Petit; Marie Claude Brindisi; Jean-Paul Pais de Barros; Laurent Lagrost; Philippe Gambert; Laurence Duvillard
Journal:  J Lipid Res       Date:  2009-01-22       Impact factor: 5.922

10.  Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.

Authors:  Rabea Asleh; Shany Blum; Shiri Kalet-Litman; Jonia Alshiek; Rachel Miller-Lotan; Roy Asaf; Wasseem Rock; Michael Aviram; Uzi Milman; Chen Shapira; Zaid Abassi; Andrew P Levy
Journal:  Diabetes       Date:  2008-07-03       Impact factor: 9.461

View more
  49 in total

Review 1.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

2.  Small high-density lipoprotein (HDL) subclasses are increased with decreased activity of HDL-associated phospholipase A₂ in subjects with prediabetes.

Authors:  Theodosios D Filippatos; Evangelos C Rizos; Vasilios Tsimihodimos; Irene F Gazi; Alexandros D Tselepis; Moses S Elisaf
Journal:  Lipids       Date:  2013-04-02       Impact factor: 1.880

3.  Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.

Authors:  Kenji Norimatsu; Takashi Kuwano; Shin-Ichiro Miura; Tomohiko Shimizu; Yuhei Shiga; Yasunori Suematsu; Yuiko Miyase; Sen Adachi; Ayumi Nakamura; Satoshi Imaizumi; Atsushi Iwata; Hiroaki Nishikawa; Yoshinari Uehara; Keijiro Saku
Journal:  Heart Vessels       Date:  2016-04-22       Impact factor: 2.037

4.  High-Density Lipoprotein Proteomic Composition, and not Efflux Capacity, Reflects Differential Modulation of Reverse Cholesterol Transport by Saturated and Monounsaturated Fat Diets.

Authors:  Marcella O'Reilly; Eugene Dillon; Weili Guo; Orla Finucane; Aoibheann McMorrow; Aoife Murphy; Claire Lyons; Daniel Jones; Miriam Ryan; Michael Gibney; Eileen Gibney; Lorraine Brennan; Margarita de la Llera Moya; Muredach P Reilly; Helen M Roche; Fiona C McGillicuddy
Journal:  Circulation       Date:  2016-04-14       Impact factor: 29.690

Review 5.  A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease.

Authors:  Michael B Fessler
Journal:  Ann Am Thorac Soc       Date:  2017-11

Review 6.  Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.

Authors:  Rai Ajit K Srivastava
Journal:  Mol Cell Biochem       Date:  2017-08-21       Impact factor: 3.396

7.  Recruitment and effectiveness by cohort in a case management intervention among American Indians and Alaska Natives with diabetes.

Authors:  Katherine A Pratte; Janette Beals; Ann Johnson; Ann Bullock; Spero M Manson; Luohua Jiang
Journal:  Transl Behav Med       Date:  2019-07-16       Impact factor: 3.046

8.  Semi-modified okara whey diet increased insulin secretion in diabetic rats fed a basal or high fat diet.

Authors:  Ahmed E Abdel-Mobdy; Marwa S Khattab; Ebtesam A Mahmoud; Eman R Mohamed; Emam A Abdel-Rahim
Journal:  Food Sci Biotechnol       Date:  2020-11-04       Impact factor: 2.391

9.  Small-angle X-ray scattering of the cholesterol incorporation into human ApoA1-POPC discoidal particles.

Authors:  Søren Roi Midtgaard; Martin Cramer Pedersen; Lise Arleth
Journal:  Biophys J       Date:  2015-07-21       Impact factor: 4.033

10.  Shoulder adhesive capsulitis and hypercholesterolemia: role of APO A1 lipoprotein polymorphism on etiology and severity.

Authors:  S Gumina; V Candela; A Castagna; M Carnovale; D Passaretti; T Venditto; G Giannicola; C Villani
Journal:  Musculoskelet Surg       Date:  2018-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.